View Older Stories View More Recent Stories

Jul 6, 2020 06:31AM Emergent BioSolutions (EBS) Signs 5-Year Agreement for Large-Scale Drug Substance Manufacturing for J&J’s (JNJ) Lead COVID-19 Vaccine Candidate
Jun 25, 2020 03:10AM Unilever's 'Fair & Lovely' to get makeover after backlash
Jun 13, 2020 02:57AM Subcutaneous Formulation of DARZALEX®▼(Daratumumab) Combination Resulted in Deep and Rapid Haematologic Responses and Improved Clinical Outcomes in the Treatment of Patients with Newly Diagnosed Li
May 8, 2020 05:21PM Biosense Webster Unveils Late-Breaking Results from PRECEPT Study in Patients with Persistent Atrial Fibrillation
Apr 3, 2020 09:00AM Results from Expert Delphi Consensus Survey on Treatment of Pulmonary Arterial Hypertension (PAH) with Oral Prostacyclin Pathway Agents (PPAs) Published in CHEST Journal
Mar 17, 2020 12:31PM German coronavirus vaccine developer CureVac denies any U.S. bid
Mar 15, 2020 08:15AM Germany tries to halt U.S. interest in firm working on coronavirus vaccine
Dec 30, 2019 04:05PM Janssen Announces Completion of Acquisition of Investigational Bermekimab from XBiotech Inc.
Dec 4, 2019 08:01AM AtriCure (ATRC) Appoints Karen Prange and Daniel Florin to Board
Dec 4, 2019 08:00AM AtriCure Names Two Industry Veterans to Board of Directors
Dec 3, 2019 09:00AM Johnson & Johnson Vision Introduces TECNIS Toric II 1-Piece IOL as New Monofocal Option for Cataract Patients with Astigmatism; Launching Multi-Center, Post-Market Clinical Trials Across U.S.
Nov 12, 2019 08:30AM Actelion Withdraws Regulatory Filings to Extend the Indication of OPSUMIT® (macitentan 10mg) in CTEPH
Oct 24, 2019 07:55AM Strong tech results propel S&P 500, Nasdaq
Oct 24, 2019 06:10AM Several states wary of $48 billion opioid settlement proposal
Oct 21, 2019 09:04AM Actelion Pharmaceuticals Reports New OPSUMIT (macitentan) Data Show Initial Combination Therapy with Tadalafil Improved Hemodynamic Clinical & Functional Parameters in Patients with PAH
Oct 21, 2019 09:00AM New OPSUMIT® (macitentan) Data Show Initial Combination Therapy with Tadalafil Improved Hemodynamic Clinical and Functional Parameters in Patients with Pulmonary Arterial Hypertension
Oct 18, 2019 07:47AM Boeing, J&J, dismal China data drag Wall Street lower
Oct 4, 2019 07:30AM Johnson & Johnson Commits $500 Million Investment Over Four Years to Help End the Epidemics of HIV and Tuberculosis
Oct 2, 2019 06:23AM Johnson & Johnson (JNJ) Settles Opioid Litigation with Two Ohio Counties for $20M
Oct 1, 2019 07:46PM Johnson & Johnson Reaches Settlement Agreement with Two Ohio Counties Ahead of Upcoming Opioid Trial
Sep 27, 2019 08:46AM Johnson & Johnson (JNJ) Reports Data from Pivotal Ph. 3 SPARTAN Study Shows 25% Reduction in Risk of Death in Patients with nmCRPC Treated with ERLEADA (apalutamide)
Sep 27, 2019 08:36AM Updated Results of the SPARTAN Study Show 25 Percent Reduction in the Risk of Death in Patients With Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC) Treated with ERLEADA® (apalutamide)
Aug 26, 2019 05:01PM Johnson & Johnson (JNJ) Will Appeal 'Flawed' Opioid Judgement in Oklahoma
Aug 26, 2019 04:59PM Johnson & Johnson To Appeal Flawed Opioid Judgment in Oklahoma
Jun 19, 2019 08:05AM Motus GI Bolsters Commercial and Quality/Regulatory Expertise with Two Key Senior Management Additions
May 20, 2019 09:00AM New Post-hoc Analysis Shows Adding UPTRAVI® (selexipag) Versus Placebo Improved Long-Term Clinical Outcomes Regardless of Time of Treatment Initiation, and Demonstrated an Even More Pronounced Treatm
May 15, 2019 06:41AM Johnson & Johnson (JNJ) to Highlight Strategy for Delivering Above-Market Growth at 2019 Pharmaceutical Business Review
May 15, 2019 06:40AM Johnson & Johnson Outlines Strategy to Deliver Above-Market Growth at 2019 Pharmaceutical Business Review
Mar 27, 2019 04:49PM Johnson & Johnson Vision Announces Availability of ACUVUE OASYS with TRANSITIONS LIGHT INTELLIGENT TECHNOLOGY in the U.S.
Mar 26, 2019 08:05AM Johnson & Johnson (JNJ) Vision's Investigational Antihistamine-Releasing Contact Lens Demonstrates Positive Phase 3 Results
Mar 26, 2019 08:00AM Johnson & Johnson Vision's Investigational Antihistamine-Releasing Contact Lens Demonstrates Positive Phase 3 Results
Mar 15, 2019 09:00AM Interim Analysis Showed Treatment with OPSUMIT® (macitentan) Associated with Significant Improvement in Right Ventricular (RV) Function and Pulmonary Vascular Resistance (PVR) in Patients with Pulmon
Feb 4, 2019 02:00AM Johnson & Johnson Vision Announces Availability in Europe of TECNIS Eyhance IOL, a Next-Generation Monofocal Intraocular Lens for Patients with Cataracts
Jan 16, 2019 04:30PM Actelion Receives Complete Response Letter from U.S. FDA for OPSUMIT® (Macitentan) Supplemental New Drug Application
Jan 3, 2019 07:12AM Veracyte (VCYT) Reports Strategic Collaboration with Johnson & Johnson (JNJ) Innovation in Battle Against Lung Cancer
Dec 12, 2018 07:04AM Janssen Pharmaceutical Reports New Phase 3 Data from ECLIPSE Study Demonstrating Superiority of TREMFYA (guselkumab)
Dec 12, 2018 07:00AM New Phase 3 data demonstrate superiority of TREMFYA® (guselkumab) vs Cosentyx® (secukinumab) in delivering PASI 90 responses in the treatment of moderate to severe plaque psoriasis at week 48
Dec 5, 2018 12:30AM Capillary Technologies hosts #ready18' summit in Singapore, empowering brands and businesses to get Consumer ready
Nov 16, 2018 07:03AM ACUVUE OASYS with Transitions Light Intelligent Technology Named Among TIME's 'Best Inventions of 2018'
Nov 16, 2018 05:30AM Are Southeast Asia's Retailers and Brands 'customer #ready'?
Nov 12, 2018 01:30AM Singapore National Eye Centre, Singapore Eye Research Institute And Johnson & Johnson Vision Set Sights On Halting Global Myopia Epidemic
Nov 7, 2018 07:58AM LifeScan Unveils New Name and Branding for the LifeScan Diabetes Institute
Nov 6, 2018 09:19AM Two Studies Measure Performance of ACUVUE OASYS with Transitions Light Intelligent Technology Contact Lenses in Simulated Sunlight, Day and Night Driving Conditions
Oct 23, 2018 01:06PM Johnson & Johnson Vision Supports Patients, Ophthalmology Community Through New Products, Data, Educational Opportunities, and Charitable Giving at the 2018 AAO Annual Meeting
Oct 8, 2018 12:00PM Johnson & Johnson Vision Launches Worldwide Campaign to #SpotlightSight in Honor of World Sight Day
Oct 4, 2018 07:32AM Arrowhead (ARWR) Announces $3.7 Billion License and Collaboration Agreements with Janssen (JNJ)
Oct 3, 2018 03:00PM HP and Johnson & Johnson challenge creative talents at Spikes Asia to transform consumer experience with digital print
Sep 27, 2018 06:08AM Janssen Biotech Announces Decision Not to Continue Collaboration with Geron Corp. (GERN) for Imetelstat
Sep 27, 2018 06:00AM Janssen Elects Not to Continue Agreement with Geron for Imetelstat
Sep 24, 2018 05:54AM Johnson & Johnson (JNJ) Company Janssen Pharmaceutical Reports Results of Esketamine Nasal Spray Phase 3 Study in Patients with Treatment-Resistant Depression
View More Recent Stories View Older Stories